Does serotonergic signaling raise prolactin by suppressing hypothalamic dopamine?

The regulation of prolactin is a finely tuned neuroendocrine balance where serotonergic signaling serves as a potent modulator of the primary inhibitory control exerted by dopamine.

Mechanistic explanations

The suppression of hypothalamic dopamine tone is the central mechanism by which serotonin elevates prolactin. Prolactin secretion from the anterior pituitary is naturally held under a continuous "brake" by dopamine released from tuberoinfundibular dopaminergic (TIDA) neurons in the arcuate nucleus.

• TIDA Neuron Inhibition: Serotonin (5-HT) acts as an indirect prolactin-releasing factor by inhibiting these TIDA neurons. Specifically, 5-HT binds to 5-HT2C receptors, which are known for high constitutive activity; this binding reduces the firing rate of TIDA neurons, thereby decreasing the concentration of dopamine in the hypophysial portal vasculature.
• Disinhibition of Lactotrophs: With less dopamine reaching the D2 receptors on pituitary lactotrophs, the inhibitory "brake" is removed (disinhibition), allowing for increased synthesis and release of prolactin.
• Receptor Specificity: While 5-HT2C receptors are primary drivers of this inhibition, 5-HT1A receptors also contribute to the stimulatory effect on prolactin. Genetic variations, such as the T allele in the HTR2C (rs3813929) polymorphism, are associated with significantly higher prolactin responses, suggesting individual susceptibility to this mechanism.

Clinical and effectiveness evidence

Pharmacological studies consistently demonstrate that increasing serotonin availability shifts the hormonal balance toward higher prolactin levels.

• Serotonergic Agents: Administration of serotonin precursors (L-tryptophan or 5-HTP) or serotonin-releasing agents (fenfluramine) leads to predictable increases in serum prolactin in human subjects.
• SSRI Impact: Selective Serotonin Reuptake Inhibitors (SSRIs) can induce hyperprolactinemia in approximately 10–20% of patients. By increasing extracellular 5-HT, these medications directly inhibit TIDA neuron activity, which can lead to clinical symptoms such as galactorrhea or sexual dysfunction.

Bottom line

The claim is strongly supported by science: serotonergic signaling raises prolactin levels by inhibiting the dopamine-producing TIDA neurons in the hypothalamus, effectively removing the primary inhibitory signal and shifting the endocrine balance toward increased prolactin secretion.